XRAY (DENTSPLY SIRONA Inc.)
Insider Trading Activity
Every open-market purchase and sale reported by XRAY officers, directors and 10%+ beneficial owners on SEC Form 4, which must be filed within two business days of the transaction. Sales often reflect scheduled 10b5-1 plans or tax withholding rather than a directional view, so read counts alongside the size and the filer.
Market data may be delayed, incomplete, or inaccurate. Not a recommendation to buy, sell, or hold any security. Verify quotes with your broker before trading. See Terms §17.
| Filed | Insider | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-08-12 | John C. Fortson | EVP & CFO | A | — | — |
| 2026-08-11 | Andrea L. Frohning | SVP, CHRO | F | — | — |
| 2026-07-01 | JONATHAN JAY MAZELSKY | Director | A | — | — |
| 2026-06-18 | JONATHAN JAY MAZELSKY | Director | Buy | — | — |
| 2026-06-16 | CLYDE HOSEIN | Director | Buy | — | — |
| 2026-06-15 | Michael J Barber | Director | Buy | — | — |
| 2026-06-15 | Brian T Gladden | Director | Buy | — | — |
| 2026-06-15 | BRIAN P MCKEON | Director | Buy | — | — |
| 2026-06-15 | BETSY D HOLDEN | Director | Buy | — | — |
| 2026-06-15 | JONATHAN JAY MAZELSKY | Director | A | — | — |
| 2026-06-05 | Michael J Barber | Director | A | — | — |
| 2026-06-05 | James D Forbes | Director | A | — | — |
| 2026-06-05 | Brian T Gladden | Director | A | — | — |
| 2026-06-05 | BETSY D HOLDEN | Director | A | — | — |
| 2026-06-05 | CLYDE HOSEIN | Director | A | — | — |
| 2026-06-05 | JONATHAN JAY MAZELSKY | Director | A | — | — |
| 2026-06-05 | BRIAN P MCKEON | Director | A | — | — |
| 2026-06-05 | LESLIE F VARON | Director | A | — | — |
| 2026-06-05 | Janet S. Vergis | Director | A | — | — |
| 2026-06-05 | Donald Zurbay | Director | A | — | — |
| 2026-06-05 | GREGORY T LUCIER | Director | MIXED | — | — |
| 2026-05-26 | Daniel T Scavilla | President, CEO & Member of BOD | F | — | — |
| 2026-04-02 | JONATHAN JAY MAZELSKY | Director | A | — | — |
| 2026-03-12 | Kevin Czerney | VP, Chief Accounting Officer | A | — | — |
| 2026-03-12 | Aldo Mariano Roberto Denti | EVP, Chief Commercial Officer | A | — | — |
| 2026-03-12 | Daniel T Scavilla | President, CEO & Member of BOD | A | — | — |
| 2026-03-09 | James D Forbes | Director | Buy | — | — |
| 2026-03-09 | GREGORY T LUCIER | Director | Buy | — | — |
| 2026-03-06 | Robert Anthony Johnson | SVP, Chief Supply Chain Office | A | — | — |
| 2026-03-06 | Robert Anthony Johnson | SVP, Chief Supply Chain Office | A | — | — |
| 2026-03-06 | Daniel T Scavilla | President, CEO & Member of BOD | A | — | — |
| 2026-03-06 | Aldo Mariano Roberto Denti | EVP, Chief Commercial Officer | A | — | — |
| 2026-03-06 | Andrea L. Frohning | SVP, CHRO | A | — | — |
| 2026-03-06 | Kevin Czerney | VP, Chief Accounting Officer | A | — | — |
| 2026-03-05 | Kevin Czerney | VP, Chief Accounting Officer | F | — | — |
| 2026-03-05 | Andrea L. Frohning | SVP, CHRO | F | — | — |
| 2026-03-05 | Robert Anthony Johnson | SVP, Chief Supply Chain Office | F | — | — |
| 2026-03-03 | James D Forbes | Director | Buy | — | — |
| 2026-03-03 | Kevin Czerney | VP, Chief Accounting Officer | A | — | — |
| 2026-03-03 | Andrea L. Frohning | SVP, CHRO | A | — | — |
| 2026-03-03 | Robert Anthony Johnson | SVP, Chief Supply Chain Office | A | — | — |
| 2026-03-03 | GREGORY T LUCIER | Director | Buy | — | — |
| 2026-02-26 | Daniel T Scavilla | President, CEO & Member of BOD | F | — | — |
| 2026-01-27 | Donald Zurbay | Director | A | — | — |
| 2026-01-13 | Michael J Barber | Director | A | — | — |
| 2026-01-13 | Kevin Czerney | VP, Chief Accounting Officer | A | — | — |
| 2026-01-13 | Willie A Deese | Director | A | — | — |
| 2026-01-13 | Andrea L. Frohning | SVP, CHRO | A | — | — |
| 2026-01-13 | Brian T Gladden | Director | A | — | — |
| 2026-01-13 | BETSY D HOLDEN | Director | A | — | — |
| Insider | Role | Shares Held | Value |
|---|---|---|---|
| — | Chairman of Exec. Committee | 45,422,215 | — |
| — | Chairman | 43,014,740 | — |
| — | President and CEO | 1,251,768 | — |
| — | Chief Executive Officer | 767,357 | — |
| — | Director | 568,161 | — |
| — | Director | 368,240 | — |
| — | President & CEO | 268,005 | — |
| — | Executive Vice President | 240,129 | — |
| — | President, CEO | 239,837 | — |
| — | Senior VP-Finance & Tax | 203,205 | — |
| — | Executive Vice President | 166,242 | — |
| — | SVP,General Counsel, Secretary | 163,545 | — |
| — | EVP & CFO | 162,241 | — |
| — | SVP, Chief Supply Chain Office | 161,819 | — |
| — | EVP, CFO | 161,279 | — |
| — | Executive Chairman, Board | 159,666 | — |
| — | President, CEO & Member of BOD | 157,754 | — |
| — | President and CEO | 154,387 | — |
| — | Director | 148,351 | — |
| — | Interim Chief Executive Office | 148,173 | — |
| — | EVP | 138,646 | — |
| — | Executive VP | 128,615 | — |
| — | Exec VP/Chief Business Officer | 119,865 | — |
| — | President & CEO Consumables | 105,083 | — |
| — | Interim Chief Exec Officer | 103,198 | — |
Form 4 reports a change in beneficial ownership by an officer, director or 10%+ holder, and must be filed within two business days of the transaction — so this is close to real time, unlike the 45-day-lagged 13F institutional data.
Transaction codes matter more than the raw buy/sell count. Code P is an open-market purchase — an insider choosing to buy with their own money, which is the signal most research treats as informative. Code S is a sale, but sales are frequently pre-scheduled under a 10b5-1 plan or cover tax withholding on vesting equity, so a run of sales often says nothing directional. Codes A and M are grants and option exercises rather than open-market decisions.
Full filing history and per-insider positions are on the XRAY quote page; the site-wide leaderboard is on the insider transactions hub.